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Abstract
 
These studies tested whether antigenic competition between T cells occurs. We generated
CD8
 
1
 
 T cell responses in H-2
 
b
 
 mice against the dominant ovalbumin epitope SIINFEKL
(ova8) and subdominant epitope KRVVFDKL, using either vaccinia virus expressing ovalbu-
min (VV-ova) or peptide-pulsed dendritic cells. CD8
 
1
 
 T cell responses were visualized by ma-
jor histocompatibility complex class I–peptide tetrameric molecules. Transfer of transgenic T
cells with high affinity for ova8 (OT1 T cells) completely inhibited the response of host anti-
gen-specific T cells to either antigen, demonstrating that T cells can directly compete with
each other for response to antigen. OT1 cells also inhibited CD8
 
1
 
 T cell responses to an unre-
lated peptide, SIYRYGGL, providing it was presented on the same dendritic cells as ova8.
These inhibitions were not due to a more rapid clearance of virus or antigen-presenting cells
(APCs) by the OT1 cells. Rather, the inhibition was caused by competition for antigen and an-
tigen-bearing cells, since it could be overcome by the injection of large numbers of antigen-
pulsed dendritic cells. These results imply that common properties of T cell responses, such as
epitope dominance and secondary response affinity maturation, are the result of competitive
interactions between antigen-bearing APC and T cell subsets.
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Introduction
 
The phenomenon of antigenic competition, in which im-
mune responses to one determinant are inhibited by simul-
taneous exposure to antigens on the same or different mol-
ecules, has been known since at least the turn of the century
(1–4). Much of the early work on competition focused on
inhibition of antibody responses to various haptens. In re-
cent years, many of the mysteries of B cell competition
have been elucidated and shown to be the consequence of
somatic hypermutation and affinity maturation (5, 6).
T cell competition for antigen has also been suggested,
usually in reference to T cell responses to subdominant or
cryptic epitopes that appear to be inhibited by responses to
other, apparently more powerful antigens (7–11). Many of
the earlier results have been attributed to differential pro-
cessing and competition for loading into a limited number
of cell surface MHC molecules between various peptide
antigens (8, 9, 12). However, not all of epitope dominance
can be explained in terms of peptide loading and affinity for
MHC (7), and there are data to suggest that T cells re-
sponding to one antigen can actively interfere with T cells
responding to another (10, 11).
More recently, the study of secondary T cell responses
has suggested a previously unpredicted mechanism for T
cell competition. Several groups have recently demon-
strated that, upon secondary challenge, the average affinity
for peptide plus MHC of the receptors (TCRs) on the re-
sponding T cells increases (13–15). This occurs in the ab-
sence of somatic mutation, the phenomenon that drives af-
finity maturation of B cell responses (5, 16). The process
appears to be due to a preferential outgrowth of the higher
affinity T cells present within the pool of primary respond-
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ers, suggesting that the higher affinity cells have a competi-
tive advantage for responding to antigen. Therefore, T cells
must compete for antigen at some level.
To study this problem, we developed a model system
with which we could directly observe competition be-
tween subsets of CD8
 
1
 
 T cells and determine the parame-
ters dictating that competition. Our data demonstrate that
T cell competition can occur at the level of access to the
limited number of antigen-bearing APCs. The data we de-
scribe are most consistent with the “interference” model
(10, 11) whereby a particular set of T cells physically ex-
cludes the access of another to antigen-bearing APCs.
 
Materials and Methods
 
Mice.
 
C57BL/6J (B6)
 
1
 
 and B6.PL-Thy1
 
a
 
/Cy (B6.PL) 6–12-
wk-old female mice were purchased from The Jackson Labora-
tory. Mice on the B6 background, transgenic for a TCR specific
for an ovalbumin peptide bound to K
 
b
 
 (OT1 transgenic mice [17,
18]) were provided by Dr. Terry Potter (National Jewish Medical
and Research Center). Mice of this strain were used at 6–10 wk
of age. No significant differences were seen when the OT1 mice
and the B6.PL recipients were male rather than female. B6 mice
expressing green fluorescent protein (GFP) under the control of
the ubiquitin promoter, UBI-GFP, were made in the National
Jewish Microinjection Facility using constructs by B. Schaefer.
The majority of cells in these animals, including the dendritic
cells (DCs) shown in this paper, express high levels of GFP
(Schaefer, B., unpublished results).
 
Antibodies and Tetramers.
 
Anti-CD8–allophycocyanin, CD44-
FITC, Thy1.2-FITC, B220-cychrome, IA
 
b
 
-biotin, and strepta-
vidin-cychrome were all purchased from BD PharMingen. K
 
b
 
covalently linked by the COOH terminus to a peptide tag that is
a substrate for BirA was produced in insect cells, biotinylated, and
bound to phycoerythrin-streptavidin (SA-PE) as described previ-
ously (19) with the following modifications. Hi5 insect cell cul-
tures were coinfected with 5–10 ml of secondary K
 
b
 
/BirA and
mouse 
 
b
 
2-microglobulin (
 
b
 
2M) baculovirus stocks. 6–8 d later,
the soluble K
 
b
 
 molecules were purified on an S19.8 (anti-
 
b
 
2M)
affinity column. Singly biotinylated K
 
b
 
/
 
b
 
2M molecules (biotiny-
lated on the COOH terminus peptide tag by the addition of the
BirA enzyme) were then combined in the appropriate ratios with
SA-PE (Rockland), and the resulting K
 
b
 
 tetramer was purified on
a sizing column. 5–10 molar excess of SIINFEKL (ova8, oval-
bumin residues 257–264), KVVRVDKL (ovalbumin residues
55–62), or SIYRYYGL
 
 
 
(which activates cells bearing the 2C
TCR in the context of K
 
b
 
 [20]) peptides were added directly to
the K
 
b
 
–SA-PE tetramer for at least 30 min at 4
 
8
 
C. The tetra-
mers were then used to stain cells. K
 
b
 
 tetramers bearing an irrel-
evant peptide, usually SIYRYYGL (i.e., same MHC, wrong
peptide), were used to establish the background staining of ex-
perimental samples. Each batch of K
 
b
 
/ova8 tetramer was tested
and normalized for binding to naive OT1 T cells before use in
experiments.
 
Virus Infection.
 
Vaccinia virus (VV) was propagated in and ti-
trated by plaque assay on cultured 143B osteosarcoma cells as de-
 
scribed previously (21). Mice were challenged with 2 
 
3 
 
10
 
6
 
 PFU
VV encoding ovalbumin (VV-ova [22]) or flu nucleoprotein
(VV-NP [22]) as described previously (21). In some cases, viral
growth in the animals was assessed by measuring virus titers in
their spleens and ovaries 5 and 7 d after infection.
 
Cell Preparation and Analysis.
 
DCs were prepared from B6
and UBI-GFP mice. Bone marrow was removed from the major
leg bones and T and B cell depleted with antibodies and rabbit
complement. The cells were cultured in 6-well plates in 1,000
U/ml of GM-CSF (from the B78Hi/GMCSF.1 cell line [23] pro-
vided by Dr. Hyam Levitsky, Johns Hopkins, Baltimore, MD)
and IL-4 in complete suspension MEM (SMEM) medium. Non-
adherent cells were removed from the cultures on day 2, centri-
fuged, and the resulting conditioned medium was put back on the
adherent cells (DCs and precursors) in conjunction with 50%
fresh medium. Every 2 d, 2 ml of fresh GM-CSF/IL-4 medium
was added to each well and the cells were given 1 
 
m
 
g/ml of LPS
on day 6 or 7 to induce the maturation of the DC precursors. The
day after LPS addition, the cells were incubated with 5 ng/ml
peptides for 2.5 h, washed, and injected in various numbers intra-
venously into B6.PL recipients. Staining the DCs before injection
with 25D1.16 (24), an antibody that recognizes the K
 
b
 
 molecule
only when in complex with the ova8 peptide, demonstrated that,
after incubation with the ova8 peptide, this peptide was uni-
formly distributed on all of the cultured DCs (data not shown).
In most experiments, T cells were isolated from spleen and
ovaries by homogenization of the tissue using a Dounce homog-
enizer or by passing the tissue through nylon screens. Red blood
cells were lysed by the addition of a buffered ammonium chloride
solution, and the nucleated cells were resuspended in complete
SMEM medium. In some cases, DCs were purified from spleen
suspensions by incubation for 45 min in 5 
 
m
 
g/ml collagenase D
(25; Boehringer) in Click’s medium with 2% fetal bovine serum
at 37
 
8
 
C. An equal volume of 0.1 mM EDTA in Click’s medium
was then added for 5 min, and the remaining tissue was passed
through nylon mesh. This was then washed with 5 mM EDTA
in Click’s medium and eventually resuspended in either Click’s
medium with 5 mM EDTA (to prevent clumping) for DC stain-
ing or in complete SMEM medium for T cell staining.
Tetramer staining was performed as described previously (15).
In brief, 2 
 
3 
 
10
 
6
 
 pooled spleen and ovary cells were incubated in
100 
 
m
 
l of FACS buffer with 5–10 
 
m
 
g/ml of tetramer in 96-well
plates at 37
 
8
 
C for 2 h. The remaining antibodies were then added
and further incubated for 30–45 min before washing and resus-
pending in FACS buffer for analysis.
Four-color FACS
 
®
 
 data were collected on a FACSCalibur™
flow cytometer and analyzed using CELLQuest™ software (Bec-
ton Dickinson). FACS
 
®
 
 data were usually analyzed by gating on
events in the lymphocyte forward/side scatter bit maps that were
CD8
 
1
 
 and IA
 
b
 
2
 
 and/or B220
 
2
 
. K
 
b
 
/ova8 tetramer staining of cells
from mice injected with a non–ovalbumin-bearing/expressing
stimulus (VV-NP–pulsed or non–peptide-pulsed DCs), or the
use of an irrelevant tetramer to stain experimental cells was used
to assess background tetramer staining. No significant differences
were seen between the two methods of background assessment.
 
Results
 
Antigen-specific T Cells Inhibit the Primary Responses to the
Same Antigen.
 
CD8
 
1
 
 T cells specific for K
 
b
 
 bound to SI-
INFEKL (ova8), the major ovalbumin peptide presented by
K
 
b
 
, were primed by immunizing mice with VV-ova. CD8
 
1
 
1
 
Abbreviations used in this paper:
 
 
 
b
 
2M, 
 
b
 
2-microglobulin; B6, C57BL/6J;
B6.PL, B6.PL-Thy1
 
a
 
/Cy; DC, dendritic cell; GFP, green fluorescent
protein; NP, nucleoprotein; SA-PE, PE-labeled streptavidin; VV, vac-
cinia virus. 
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T cells specific for K
 
b
 
/ova8 were detected using SA-PE
bound to this MHC–peptide combination. After intrave-
nous challenge of mice with 2 
 
3 
 
10
 
6
 
 PFU of VV-ova, the
peak of the ova8-specific CD8
 
1
 
 T cell response was be-
tween days 9 and 12 (Fig. 1 A, and data not shown). The
ova8-specific cells at this time point expressed high levels of
CD44 (Fig. 1 A) and very late antigen 4 (VLA-4) and low
levels of L-selectin (data not shown). Secondary challenge
 
of these mice 25 d after primary immunization resulted in a
more rapid and greater magnitude of expansion of the ova8-
specific T cells seen on day 5 after secondary challenge (Fig.
1 B). In addition, secondary challenge caused a significant
outgrowth of T cells with a higher level of fluorescence af-
ter staining with K
 
b
 
/ova8 tetramer (Fig. 1 B). Staining of
the cells with anti-CD3 demonstrated that this increase in
fluorescence was not due to an increase in TCR levels (data
not shown). As previous studies have indicated (13–15), this
increased staining suggests that these cells possessed a higher
intrinsic affinity for antigen. While formally this increased
binding to tetramer may be due to altered mobility or geo-
metric distribution of TCR or to increased CD8 coreceptor
function, in our hands the level of tetramer binding, when
corrected for TCR levels, correlates most consistently with
an increase in TCR affinity for antigen–MHC (26).
If T cells compete with each other during responses to
antigen, we reasoned that the transfer of K
 
b
 
/ova8-specific
T cells into mice before VV-ova exposure might inhibit
the response of the endogenous T cells. To test this idea,
B6 (Thy1.2
 
1
 
) K
 
b
 
/ova8-specific OT1 transgenic T cells
were transferred to B6.PL (Thy1.1
 
1
 
) mice. The recipients
were then challenged with VV-ova. Cells from the trans-
ferred mice were stained with anti-Thy1.2 and K
 
b
 
/ova8
tetramer, and the responses of both transferred and endoge-
nous K
 
b
 
/ova8-specific T cells were thus measured and
compared (Fig. 2). The transferred OT1 cells strongly in-
hibited increases in the numbers of K
 
b
 
/ova8-specific en-
dogenous T cells (Fig. 2 A). This inhibition was propor-
tional to the expansion of the transferred OT1 cells, though
only a small expansion of the transferred cells almost com-
pletely inhibited the endogenous T cell response (Fig. 2 B).
 
Inhibition by Antigen-specific T Cells Is Not Due to Reduc-
tions in Antigen Levels.
 
One concern was that the reduc-
tion of the endogenous T cell response in the transferred
Figure 1. Tetramers can detect ovalbumin-specific T cells in VV-ova–
immunized mice. B6 mice were immunized with 2 3 106 PFU VV-NP
or VV-ova intravenously. 25 d later, some of the VV-ova–primed mice
were reexposed to the same virus. 9 d after the primary infection or 5 d
after the secondary infection, spleen and ovary cells were isolated from
the animals, pooled, and stained with the Kb/ova8 tetramer and anti-CD8
as described in Materials and Methods. (A) Cells from mice infected once
with VV-NP (left) or VV-ova (right). (B) Cells from mice undergoing
primary or secondary responses to VV-ova. Background staining is from
VV-NP–infected mice stained with the Kb/ova8 tetramer.
Figure 2. Transferred OT1
cells compete against the primary
response of endogenous Kb/
ova8-specific CD81 T cells.
B6.PL mice, with or without the
transfer of 0.2–1 3 106 B6 OT1
transgenic T cells, were immu-
nized with VV-ova as in the leg-
end to Fig. 1. 9 d after infection,
pooled ovary and spleen cells
were stained with the Kb/ova8
tetramer as described in Materials
and Methods. (A) Data were an-
alyzed by gating on CD81class
II2 events. The dot plots were
additionally gated on all Thy1.22
events (R3 gate) to generate the
histograms (right). The percent-
age given above the marker is
the percentage of the total
Thy1.22CD81 T cells staining
positively for tetramer binding.
Background (solid histogram) is from irrelevant tetramer staining of experimental cells. (B) Data pooled from two separate experiments demonstrating the
inverse relationship between the expansion of the transferred cells and the expansion of the endogenous cells. The y-axis is the percentage of endogenous
tetramer-staining cells out of all endogenous (Thy1.22) cells. The x-axis is the percentage of transferred (Thy1.21) cells out of both Thy1.21 and
Thy1.22 cells. The data shown are representative of six separate experiments. 
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mice was due to a more rapid elimination of virus, and
therefore elimination of antigen, in mice receiving the
transferred cells compared with nontransferred controls. To
find out whether this was true, mice with and without
transferred OT1 cells were challenged with VV-ova and vi-
ral titers in spleen and ovary were measured. The data dem-
onstrate that viral titers in transferred mice were the same as
those in nontransferred controls (Fig. 3). This was true even
if the numbers of OT1 cells transferred were much higher
than those required to suppress the endogenous T cell re-
sponse (compare data in Figs. 2 and 3). Thus, the failure of
the endogenous T cell response in mice given OT1 cells
was not due to a more rapid clearance of antigen.
 
Transfer of OT1 Cells Inhibits Secondary Responses to Anti-
gen.
 
We next tested whether transferred OT1 cells could
inhibit the response of primed T cells. B6.PL mice were
challenged with VV-ova and 25 d later were rechallenged
with the same virus with or without transfer of OT1 trans-
genic T cells. The number of transferred cells was selected
such that they would be in approximately the same num-
bers in the recipient as the endogenous K
 
b
 
/ova8-specific
memory cells (
 
z
 
0.25% of all CD8
 
1
 
 T cells; data not
shown). Nontransferred mice demonstrated significant ex-
pansion and affinity maturation of the endogenous T cell
population after secondary challenge. However, the expan-
sion and affinity maturation of the established endogenous
memory T cells were strongly inhibited by the transferred
cells (Fig. 4). Given the high affinity of the OT1 TCR for
antigen (1–6 
 
m
 
M), these data suggest that the affinity of a
given T cell enhances its ability to compete for access to,
and expansion from, antigen stimulation. It should be
noted that the low level of tetramer staining of the OT1
cells after activation is due primarily to a high degree of re-
ceptor downregulation (see Discussion).
 
T Cell Inhibition Is Not Antigen Specific.
 
There are sev-
eral explanations for the inhibitory effect of the transferred
cells. For example, they might compete with endogenous
cells for access to the limited number of K
 
b
 
/ova8 com-
plexes on the APCs. Alternatively, they might compete for
access to APCs in an antigen-nonspecific way. Finally, they
might compete for factors, such as growth-promoting cy-
tokines, that are unrelated to APC function. To find out
whether the transferred cells were inhibiting access to the
specific ligand, K
 
b
 
/ova8, we tested whether or not they
could inhibit responses to a different antigen. We chose to
study responses to K
 
b
 
 bound to the subdominant ovalbu-
min peptide, KVVRFDKL. A previous report demon-
strated that the dominance of the ova8 epitope is not due
to a lack of subdominant-specific T cells in the repertoire
but rather because the dominant epitope has a higher affin-
ity for MHC binding than the subdominant epitope does
and is therefore more efficiently presented (12). The trans-
fer of OT1 cells should not affect this difference. Mice
were infected with VV-ova, and K
 
b
 
/ KVVRFDKL-specific
T cells were detected using K
 
b
 
 tetramers made with the
KVVRFDKL peptide. A small population of KVVR-
FDKL-specific T cells was detectable at 
 
z
 
1/5–1/10 of the
numbers of the K
 
b
 
/ova8-specific population in VV-ova–
infected mice (Figs. 2 and 5). Transfer of OT1 cells did in-
deed inhibit the response to the subdominant epitope (Fig.
5). Transfer of T cells specific for a lymphocytic chorio-
meningitis virus peptide bound to D
 
b
 
 did not reduce the
endogenous responses to K
 
b
 
/ova8 in mice primed with
VV-ova (data not shown).
 
Non–Antigen-specific Competition Occurs Only When the
Different Epitopes Are Presented on the Same APC.
 
These
experiments showed that, in order to inhibit endogenous T
cell proliferation, the transferred cells must be activated, but
need not be recognizing the same antigen as the inhibited
cells. The transferred cells may therefore be operating ei-
ther by restricting access to APCs in an antigen-nonspecific
fashion, or by competing for some other limiting factor(s)
such as cytokines. If the transferred cells are restricting ac-
cess to the APCs, then we predicted that this non–antigen-
specific competition would occur only when different
epitopes are presented on the same APC. In contrast, if the
cells are competing for soluble factors, then the transferred
Figure 3. Transfer of OT1
cells does not cause accelerated
clearance of VV-ova. B6.PL
mice with or without transfer of
106 B6 OT1 transgenic T cells
were immunized with VV-ova
as in the legend to Fig. 1. On
days 5 and 7 after infection, viral
plaque assays were performed on
pooled spleen and ovary tissue.
The data shown are from tripli-
cate titers of triplicate mice per
time point. As a control, a small
number of T cells were stained
with tetramer from the transferred group of mice to insure that the trans-
ferred cells had indeed responded to the viral challenge (data not shown).
Figure 4. Transferred OT1 cells compete against the secondary re-
sponse of endogenous Kb/ova8-specific CD81 T cells and inhibit affinity
maturation. 25 d after initial VV-ova immunization, B6.PL mice were
transferred with 3 3 106 OT1 T cells and rechallenged with VV-ova. This
response was compared with that of B6.PL mice given a secondary VV-
ova immunization without OT1 T cell transfer. The data were analyzed as
described in the legend to Fig. 2. The numbers above the markers in the
histograms are the mean fluorescence intensity of the tetramer-staining
cells. The data presented are representative of three separate experiments.1109 Kedl et al.
cells may be able to compete with cells of other specificities
as long as they are activated at the same time but not neces-
sarily by the same APC. To test this possibility, we changed
our priming stimulus to a challenge with in vitro–cultured
and peptide-pulsed DCs. Peptide-pulsed DCs stimulated a
vigorous response (Fig. 6 A) that peaked around day 5 after
DC injection (Fig. 6 B). It is interesting to note that the
distribution of tetramer staining on T cells in response to
DC challenge was broader than that seen in response to
VV-ova infection (compare Figs. 2 and 6). This suggests
that the immunization with DCs pulsed with a single pep-
tide epitope generated T cells with a more diverse range of
affinities than did immunization with a multiepitope-
encoding virus infection (see Discussion). Transferred OT1
cells inhibited the endogenous response to limited numbers
of DCs injected (Fig. 6 C), indicating that competition
with the endogenous T cells was still observable under this
priming regimen.
We next used two different peptide epitopes in the DC
immunizations to determine the importance of the local-
ization of each epitope for the degree and specificity of
competition. Cultured DCs were pulsed with either the
ova8 peptide, the SIYRYYGL peptide (20), or both pep-
tides together. Mice were injected with equal numbers of
DCs bearing each epitope separately or with DCs bearing
both epitopes simultaneously. The DCs were injected into
mice with or without the transfer of OT1 T cells, and 5 d
later the CD81 T cell responses to each epitope were as-
sessed by staining the cells with either tetramer.
In the absence of the OT1 T cells, mice injected with
single or double peptide–pulsed DCs generated vigorous
responses against both peptides (Fig. 7, A and B, top two
rows). When mice were immunized with two sets of DCs,
each pulsed with one peptide, in the presence of OT1 cells,
the endogenous response against the SIYRYYGL peptide
was not affected while the ova8-specific response was se-
verely inhibited (Fig. 7, A and B, third row). However,
when mice were immunized with DCs bearing both pep-
tides simultaneously, the transferred OT1 cells inhibited
the endogenous response to both peptides (Fig. 7, A and B,
bottom row). The competition by OT1 cells with T cells
responding to either peptide can be seen in terms of both
the percentage (Fig. 7, A and B) and the total number of
responding tetramer-staining cells (Fig. 7 C). This inhibi-
tion occurred against each peptide to different degrees,
with the SIYRYYGL response inhibited 3–5-fold and the
ova8 response inhibited .100-fold (Fig. 7 C).
Thus, the transferred OT1 cells are able to compete with
endogenous T cells responding either to the same peptide
or to a different peptide, provided that the OT1 cells can
react with the same APCs as the endogenous T cells. The
fact that endogenous responses to the peptide recognized
by OT1 cells are more strongly inhibited than responses to
an unrelated peptide on the same APC indicated that OT1
cells might be inhibiting in two different ways. They ap-
pear to be competing simply for access to DCs, thus inhib-
iting responses to any peptide borne by the DCs with
which they are reacting. In addition, the OT1 cells appear
to be even more severely inhibiting responses to the very
peptide they themselves recognize. This suggests that com-
petition between T cells can occur both at the level of ac-
cess to the entire APC and at the level of access to peptide,
and that the competition for the latter is more efficient than
for the former.
Competing T Cells Do Not Kill Antigen-presenting DCs.
Since the transferred OT1 cells were CTL precursors, it was
possible that they inhibited the endogenous T cells by pre-
maturely killing antigen-bearing APCs. To determine the
fate of the injected DCs, we cultured bone marrow from
mice transgenic for GFP driven by the ubiquitin promoter
Figure 5. Competition of OT1 T cells with endogenous T cells is not
antigen specific. B6.PL mice, with and without transfer of 5 3 105 OT1
T cells, were immunized with VV-ova intravenously. 9 d after the pri-
mary infection, spleen and ovary cells were isolated from the animals,
pooled, and stained with the minor ovalbumin epitope Kb/KVVRDKL
tetramer. Cells were analyzed as described in the legend to Fig. 2. Back-
ground staining was determined by irrelevant tetramer staining of experi-
mental cells.
Figure 6. Peptide-pulsed DCs
induce a vigorous CD81 T cell
response that can be inhibited by
OT1 T cell transfer. Bone mar-
row was removed from the ma-
jor leg bones of B6 mice, T and
B cell depleted, and cultured
with IL-4 and GM-CSF for 8 d.
ova8 peptide was added to the
cultures at 5 mg/ml for 2 h at
378C. The resulting DCs were
harvested and injected intrave-
nously into B6 recipients at 106/
mouse. On days 5, 7, and 9 after
DC injection, the spleens were
harvested and stained with Kb/
ova8 tetramer. (A) Dot plots
from the day 5 time point gated
on live, CD81class II2 events.
Companion stains showed the
Kb/ova8 tetramer staining cells
to also be predominantly blasts
and CD251 at only the day 5 time point, and L-selectinlo and CD44hi at
all time points (data not shown). (B) Tetramer staining histograms of live,
CD81class II2CD44hi gated events of spleen cells from DC-challenged
mice analyzed at the times indicated after initial DC challenge. (C) Mice
immunized as in A with (1OT1) and without (No trans) the transfer of
5 3 105 OT1 T cells.1110 T Cell Competition for APCs
(UBI-GFP). Nearly all of the cells from UBI-GFP mice, in-
cluding the DCs, fluoresce green (Schaefer, B., unpublished
results). B6.PL mice were immunized with GFP1 ova8-
pulsed DCs, with and without transfer of OT1 cells, and 5 d
later the spleens were removed and treated with collagenase
D to release the DCs (25). FACS® analysis showed that the
recovery of GFP1 DCs was unaffected by simultaneous
transfer of OT1 cells (Fig. 8, A and B), despite the strong
response of the Kb/ova8-specific endogenous or transferred
cells (see Fig. 9). Thus, antigen-presenting DCs were not
more rapidly cleared in OT1 transferred mice. It should be
noted that ova8-specific T cells did not achieve effector
function, with respect to lytic activity or IFN-g secretion,
until day 7 after DC injection (data not shown). Therefore
clearance of the injected DCs by CD81 T cell lytic function
could not have occurred at the day 5 time point.
Competition by T Cells Is Prevented by Increases in Antigen-
presenting DCs. From these experiments, we concluded
that the transferred OT1 cells competed for access to some
APC-related factor to the exclusion of the endogenous T
cells. If this were correct, then we predicted that it should
be possible to elevate the number of antigen-bearing APCs
to a level above which the transferred cells could no
longer effectively out-compete the endogenous T cells.
To test this prediction, ova8-pulsed DCs were again in-
jected in increasing numbers into B6.PL mice with or
without transfer of a small number of OT1 T cells.
In the absence of OT1-transferred cells, there was a vig-
orous endogenous response that increased in magnitude as
Figure 7. Non–antigen-specific competition of
OT1 T cells is dependent on the copresentation of
epitopes on a common APC. B6.PL mice with and
without the transfer of 1–2 3 106 OT1 cells were
challenged intravenously with antigen-pulsed DCs
in two different ways: 1.5 3 106 0.5 mg/ml ova8-
pulsed DCs plus 1.5 3 106 0.5 mg/ml SIYRYYGL-
pulsed DCs (Separate DC); or 1.5 3 106 DCs pulsed
with both peptides (Same DC). 5 d after DC chal-
lenge, the spleens were harvested and the cells were
stained with either the Kb/SIYRYYGL tetramer
(A) or the Kb/ova8 tetramer (B). The data for the
dot plots were gated on live, CD81class II2 events,
and the data for the histograms were further gated
on Thy1.22 events (R3). The percentages given are
the percentages of the total endogenous CD81 T
cell population. The total cell number was multi-
plied by the percent CD81 in each sample, which
was then multiplied by the percentage of tetramer-
staining events in A and B to give the total number
of tetramer-staining cells in each sample (C). The
average and standard deviation were calculated from
four mice per group.
the number of priming DCs was increased (Fig. 9 A).
Transferred OT1 cells inhibited the response of the endog-
enous T cells when the mice were challenged with small
numbers of DCs (Fig. 9 B, top). However, as the numbers
of DCs were increased, the endogenous response became
readily observable (Fig. 9 B). These results show that trans-
ferred OT1 cells inhibited the response of endogenous T
cells to antigen by competing for access to the antigen-pre-
senting DCs.
Discussion
The data presented here show that CD81 T cells can
compete with each other during responses to antigen. The
competition is alleviated by increasing the numbers of
APCs in the animal; hence, it involves some aspect of T
cell–APC interaction. However, successful competition
does not require that the T cells be responding to the same
antigen, nor does it involve killing of the APCs. Thus,
competition may be due to limited availability of some sol-
uble factor made by DCs, or limited accessibility to mole-
cules such as MHC or costimulatory proteins on the surface
of the DCs. These data agree remarkably well with work
from K. Karre’s group on the inhibitory effects of responses
to major epitopes against responses to minor epitopes (10,
11). Our experimental system has the advantage of being
able to identify and quantify competing subsets of antigen-
specific T cells, as well as the antigen-bearing APCs, di-
rectly ex vivo.1111 Kedl et al.
The conclusion that antigen-bearing APCs are limiting is
surprising, especially in the experiments described here in
which mice were immunized with VV-ova. During infec-
tion, very high titers of VV are produced, demonstrating
that the animal contains plenty of antigen (Fig. 3). At first
sight, this suggests that antigen presentation should not be
limiting. However, most of the cells infected by VV are ep-
ithelial in nature. Not being epithelial in lineage, APCs
such as DCs are probably not directly infected by VV. This
idea is supported by the fact that we have never seen ex-
pression of GFP in the APCs of mice infected with a VV
coding for GFP (data not shown), suggesting that APCs
must acquire VV epitopes indirectly. Therefore, presenta-
tion of antigens encoded by VV to naive T cells within the
secondary lymphoid tissue may indeed be limiting, even in
animals experiencing fulminant VV production.
Most viruses used experimentally, such as lymphocytic
choriomeningitis virus and influenza, demonstrate strong
dominance of their CD81 T cell responses towards a lim-
ited number of epitopes despite a potential abundance of
diverse epitopes from these viruses. This epitope domi-
nance has been shown to be due in part to differences in
processing and loading of the peptides into class I (8, 9, 12).
However, recent work by Chen et al. demonstrated that
some of these epitopes do not appear to have significant
differences in their levels of presentation (7). Our data sug-
gest that an additional reason for epitope dominance may
be competition of T cells specific for one antigen with T
cells with other specificities. Consistent with this is the fact
that preimmunization with a subdominant epitope results
in a loss of its subdominant status upon subsequent viral in-
fection (7, 27, 28). Presumably, generation of a large num-
ber of T cells specific for the subdominant epitope allows
them to compete more effectively for access to APCs with
cells specific for the traditionally more dominant epitope. It
is interesting to note that our model predicts that if primary
infection leads to a significant immunodominance of a
given epitope, then that epitope is likely to dominate the
secondary response to an even greater extent due to the
competitive advantage of sheer numbers of epitope-specific
cells. This phenomenon has been observed in our experi-
mental system (data not shown) and others (7), and demon-
strates another situation in which competition could play a
role in tailoring T cell responses.
The clone of OT1 T cells was produced after several in
vivo and in vitro challenges with antigen (17, 18), and the
OT1 TCR has a high affinity for antigen (1–6 mM) (29,
30). It should be noted that the tetramer fluorescence of
the OT1 cells in primed mice at times appears similar to the
tetramer fluorescence of some of the endogenous T cells
(see Figs. 2, 4, and 8). This does not mean that these T cells
have as high an affinity for antigen as the OT1 cells. The
OT1 TCR is downregulated four- to sixfold more than
that of the endogenous T cells upon activation, based on
CD3 staining profiles (data not shown). When the tetramer
fluorescence is normalized to levels of CD3, the data sug-
gest that the OT1 T cells have significantly higher affinity
(5–10-fold) for antigen than the majority of the primary
population of responding T cells (data not shown).
Figure 8. Mice given OT1 T cells do not clear antigen-bearing DCs
more rapidly than nontransferred mice. B6.PL mice with and without
transfer of 2.5 3 105 OT1 T cells were challenged with increasing num-
bers of UBI-GFP bone marrow DCs pulsed with 5 ng/ml of ova8 peptide.
DCs from the UBI-GFP mice were cultured as in the legend to Fig. 6. 5 d
later, splenic DCs were isolated by collagenase treatment and assessed for
the presence of GFP1 events. (A) GFP histograms of mice with and with-
out transfer of OT1 cells. All GFP1 cells were also class II1 (not shown).
(B) Percentage of GFP1 events of total spleen cells as shown in A, ex-
pressed as the average and standard deviation from three mice per group.
Figure 9. OT1 T cells compete with endoge-
nous T cells for access to DCs. B6.PL mice with
and without the transfer of 2.5 3 105 OT1 cells
were challenged intravenously with B6 bone mar-
row DCs pulsed with 5 ng/ml of ova8 peptide. 5 d
later, spleen cells were stained with tetramer as in
the legend to Fig. 2. (A) Nontransferred B6.PL re-
sponse to increasing numbers of DCs injected. The
dot plots are gated on CD81class II2 events. The
histograms were further gated on Thy1.22 (gate
R3) events. (B) OT1-transferred B6.PL response
to increasing numbers of DCs injected. Gating
strategy as in A. (C) The average and standard de-
viation of endogenous T cell percentages from
OT1-transferred and nontransferred mice, three
mice per treatment.1112 T Cell Competition for APCs
It may be that it is this very high affinity for antigen that
allows OT1 cells to compete so effectively with endoge-
nous T cells responding to the same peptide. It has previ-
ously been shown that repeated immunization reduces the
oligoclonality of the responding T cells (31). Moreover, the
surviving cells in such immunizations have a higher affinity
for antigen than cells in primary infections/immunizations
(13–15). Perhaps these two types of experiments are mani-
festations of the same phenomenon, the ability of high af-
finity T cells to outgrow other cells during repeated chal-
lenges with antigen. High affinity for antigen may allow a
given T cell to gain and maintain an interaction with anti-
gen-bearing APCs to the exclusion of other lower affinity
T cells. Inhibition of the lower affinity T cells of the same
specificity may also occur because of physical removal and
internalization of the MHC–peptide complex from the sur-
face of a cognate APC by the higher affinity T cells, as re-
cent data have suggested (32).
However, at least some of the inhibition of lower affinity
T cells is due simply to the fact that a given APC has a lim-
ited surface area with which to interact with T cells and the
high affinity T cells preferentially occupy that space. The
experiments demonstrating that the high affinity OT1 cells
can inhibit responses to other antigens presented by the
same APC are in support of this (Figs. 5 and 7). It is inter-
esting to note that we observed little inhibition of the re-
sponse against the ova8 epitope when the SIYRYYGL
epitope was on the same DC in the absence of the OT1
cells (Fig. 7, A and B, second row). This is consistent with
the prediction that while the high affinity OT1 cells com-
pete with both epitopes effectively, the low affinity endog-
enous cells are inefficient at competing with T cells of
other specificities. Further experiments are being done to
determine whether cells with decreasing affinity relative
to OT1 T cells have a correspondingly decreasing ability to
compete for access to antigen-bearing APCs in normal pri-
mary and secondary responses.
In light of this notion, it is tempting to consider whether
suppressor/regulatory T cells act by competing for access to
antigen-bearing APCs. Regulatory T cells subdue the acti-
vation of other T cells, and much of this inhibitory activity
has been attributed to the effect of Th1- and Th2-related
cytokines on the proliferation of the opposite type response
(33–35). Our data suggest that regulatory T cells may com-
pete against other T cells for access to APCs, either for an-
tigen or cytokine binding. To determine whether this is
truly a mechanism of regulatory T cell–mediated inhibi-
tion, experiments must be done in which tetramer-staining
regulatory T cells are generated in vivo and then assessed
for their ability to compete with normal T cells in response
to antigen.
Finally, our data suggest that T cell competition is likely
to play a role in modifying T cell responses in vaccination
strategies. Our demonstration of OT1-mediated inhibition
of the minor ovalbumin epitope response demonstrates that
competition can occur between T cells of different speci-
ficities and that this competition probably shapes the affin-
ity and magnitude of the responding T cell population to
each antigen. For example, data in this report show that
DC immunization with one or even two epitopes results in
a broader range of T cell affinities than does VV-ova
immunization (compare level of fluorescence of the tet-
ramer-positive population in Fig. 2 and Figs. 6, 7, and 9).
Immunization with VV-ova activates potentially compet-
ing VV-specific T cells, whereas immunization with DCs
does not. Some of this effect may be due to differences in
antigen levels between the two procedures. However, a
portion of this phenomenon is likely due to the fact that
the peptide-pulsed DCs present a small number of epitopes
and therefore the ova8-specific population of T cells is sub-
jected to competition only from a limited number of cells
with limited specificities. Given this, we speculate that
competition between T cells could eventually be exploited
to encourage the growth of higher affinity T cells while
limiting the growth of lower affinity cells.
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